Remdesivir in moderate to severe COVID-19: A matter of time?
...Published in Pharmacological Research
A bibliometric study of COVID-19 research in Web of Science.
Published in Pharmacological research
Corrigendum to “Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19” [Pharma...
Published in Pharmacological Research
A new stratification model for a population health risk assessment, based on a large cohort of patients infected by COVI...
Published in Pharmacological Research
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development
...Published in Pharmacological Research
ga1
International policies and challenges on the legalization of traditional medicine/herbal medicines in the fight against ...
Published in Pharmacological Research
ga1
Methodological education in response to the quality of COVID-19 publications.
Published in Pharmacological research
Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
...Published in Pharmacological Research
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all ...
...Published in Pharmacological research
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.
Published in Pharmacological research
